Company / Current Assets per Share
Neogen Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$2.66
FY2025
5-year range
$2.66 / $5.83
FY2021-FY2025
Trend
-2.4%
vs FY2024
Sector context
#150 of 163
Health Care
What the data says
Among 163 Health Care companies, Neogen is in the bottom 8% for current assets per share. Current Assets per Share has declined for 3 consecutive years, from $5.83 in FY2022 to $2.66 in FY2025.
Based on SEC 10-K filings.
2.66 in FY2025 with a 5-year CAGR of -23.7%.
Declined from $5.44 to $2.66 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -23.0%
- 5-Year CAGR
- -23.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 163This company $2.66 Sector average $52.74
▼
-95.0% below sector average
Key checks
Key Insights
- Neogen's current assets per share has declined for 3 consecutive years.
- In FY2025, current assets per share decreased 2.4% year-over-year.
- Ranks #150 out of 163 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.66 | -2.4% |
| FY2024 | $2.72 | -49.9% |
| FY2023 | $5.44 | -6.8% |
| FY2022 | $5.83 | +4.4% |
| FY2021 | $5.59 | -45.7% |
| FY2020 | $10.29 | +18.4% |
| FY2019 | $8.69 | +17.8% |
| FY2018 | $7.38 | -5.4% |
| FY2017 | $7.80 | +16.6% |
| FY2016 | $6.69 | +6.2% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026